An eye patch for pregnant women with hyperthyroidism and exophthalmos
Patent Information
- Application Number
- CN202520929369.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2025-05-12
- Publication Date
- 2026-09-01
- Estimated Expiration
- 2035-05-12
AI Technical Summary
[0005]针对现有技术的不足,本实用新型提供了一种妊娠期甲亢突眼患者用眼罩,解决了现有技术中部分眼罩无法适应不同患者个体差异的问题,提高了佩戴的舒适性和治疗效果
本实用新型提供一种妊娠期甲亢突眼患者用眼罩,包含两相同的眼罩框体,两所述眼罩框体连接时相对的一侧设置有类三角状的连接带,且类三角状的连接带配合设置有魔术子贴以及魔术母贴,使得眼罩能够灵活适应不同患者的面部轮廓(眼距)和眼球突出程度,调节连接带的连接长度,从而确保了最佳的佩戴舒适性和贴合度,有效避免了传统眼罩因固定尺寸带来的不适感,同时类三角状的连接带在连接后底部形成缺口,该缺口可对准使用者的鼻梁位置,使得眼罩佩戴更贴合。其次,眼罩框体内设有的可拆卸置药组件,包含吸药层、渗药护垫层及软纱层,不仅便于置药组件的更换和安装,还通过多层结构的协同作用,促进了药物的均匀分布和高效吸收,直接针对眼部症状进行治疗,显著提高了治疗效果,且可根据患者的不同选择安装不同厚度的置药组件,使得更好的适配不同眼球突出程度的患者,提高佩戴舒适性。此外,眼罩框体的两侧的开口分别设置有保护盖和软性贴肤层,保护盖有效防止外部污染,保持内部清洁,同时也可打开保证眼部的透气性,而软性贴肤层则提供额外的舒适感和皮肤保护,进一步增强了患者的使用体验。同时,所述置药框体与所述眼罩框体上还配备了卡扣组件和加药口,简化了置药框体的组装、拆卸清洗及药物添加过程,使得患者或医护人员能够轻松管理眼罩的使用和维护。因此,本实用新型提供的妊娠期甲亢突眼患者用眼罩显著提高了患者的佩戴舒适性,还提高了药物治疗的效率和效果,为妊娠期甲亢突眼患者提供了一种安全、有效且舒适的眼部护理眼罩。
Smart Images

Figure CN224699326U_ABST
Abstract
Description
Technical Field
[0001] This utility model relates to the field of eye mask technology, specifically an eye mask for pregnant patients with hyperthyroidism and exophthalmos. Background Technology
[0002] Hyperthyroidism is a common endocrine disorder caused by the thyroid gland producing excessive amounts of thyroid hormones. The incidence of hyperthyroidism may increase during pregnancy due to hormonal changes, especially in pregnant women with pre-existing thyroid disease. A common complication of hyperthyroidism is exophthalmos, characterized by protruding eyeballs, which can lead to symptoms such as dry eyes, pain, and decreased vision, and in severe cases, can significantly impact a patient's quality of life.
[0003] For pregnant women with Graves' ophthalmopathy, effective treatment methods are particularly important. Currently, common treatments include medication and eye care. While medication is effective, special attention must be paid to its safety and efficacy during pregnancy; therefore, non-pharmacological treatments are increasingly gaining importance. Eye care is a crucial component of managing Graves' ophthalmopathy symptoms; appropriate care can help alleviate eye discomfort and improve quality of life.
[0004] However, existing eye care tools, especially eye masks, have some shortcomings. Traditional eye mask designs are usually fixed and cannot adapt to individual differences among patients, causing discomfort and pressure when worn. They may also affect the even distribution and absorption of medications. Therefore, it is necessary to provide an eye mask that can adapt to individual patient differences, ensure comfortable wear, and improve drug absorption. Utility Model Content
[0005] To address the shortcomings of existing technologies, this invention provides an eye mask for pregnant patients with hyperthyroidism and exophthalmos, which solves the problem that some existing eye masks cannot adapt to individual differences among patients, thus improving wearing comfort and treatment effectiveness.
[0006] An eye mask for pregnant patients with hyperthyroidism and exophthalmos includes two identical eye mask frames. When the two eye mask frames are connected, their opposite sides are provided with interlocking elastic bands. When the two eye mask frames are connected, their opposite sides are provided with a triangular connecting strap. When the two connecting straps are connected, their opposite sides are respectively provided with a Velcro closure and a Velcro closure. Both sides of the thickness direction of the two eye mask frames are provided with openings. A protective cover is pivotally connected to one side of one opening. The outer diameter of the protective cover is equal to or slightly smaller than the inner diameter of the opening. A soft skin-adhesive layer is provided around the outer edge of one side of the other opening. A drug-dispensing component is detachably provided inside the eye mask frame. The drug-dispensing component includes a drug-dispensing frame and a drug-absorbing layer, a drug-absorbing pad layer, and a soft gauze layer disposed on the drug-dispensing frame. The drug-dispensing frame is provided with a buckle assembly and a drug dispensing port that cooperate with the eye mask frame.
[0007] Preferably, the buckle assembly includes a buckle that is annularly disposed on the outside of the medication frame, and a groove that is recessed from the inner sidewall to the outer side of the eye mask frame.
[0008] Preferably, the buckle is a T-shaped buckle, and the groove is a T-shaped groove adapted to the T-shaped buckle.
[0009] Furthermore, one of the T-shaped buckles and one of the T-shaped grooves are provided with identification marks, and the identification marks correspond to each other when the drug placement component is engaged with the eye mask frame.
[0010] Furthermore, the drug inlet is a cylindrical drug inlet, and both the cylindrical drug inlet of the drug placement frame and the eye mask frame are provided with a soft silicone one-way cap. The protruding end of the soft silicone one-way cap of the eye mask frame faces the outside of the eye mask frame, and the protruding end of the soft silicone one-way cap of the drug placement frame faces the inside of the drug placement frame.
[0011] Furthermore, the soft silicone one-way cap is provided with a cross-shaped slit opening.
[0012] Preferably, the elastic band is provided with fastening components at both ends for adjusting the tension of the elastic band.
[0013] Preferably, a support baffle is provided in the middle of the eye mask frame, and the middle of the support baffle is provided with a through circular hole.
[0014] Preferably, a rubber ring is provided inside the opening of the goggle frame protective cover on one side of the protective cover, and the inner diameter of the rubber ring is the same as the outer diameter of the protective cover.
[0015] Preferably, the soft skin-adhesive layer is a soft rubber gasket.
[0016] Compared with the prior art, the present invention has the following beneficial effects: This invention provides an eye mask for pregnant women with hyperthyroidism and exophthalmos, comprising two identical eye mask frames. When the two frames are connected, a triangular connecting strap is provided on opposite sides. This triangular connecting strap is fitted with Velcro fasteners and Velcro ties, allowing the eye mask to flexibly adapt to different patients' facial contours (interocular distance) and degrees of eye protrusion. Adjusting the length of the connecting strap ensures optimal wearing comfort and fit, effectively avoiding the discomfort caused by fixed sizes in traditional eye masks. Furthermore, the triangular connecting strap forms a notch at the bottom after connection, which can be aligned with the user's nose bridge for a more snug fit. Secondly, the eye mask frame contains a detachable drug-filled component, comprising an absorbent layer, a drug-absorbing pad layer, and a soft gauze layer. This not only facilitates the replacement and installation of the drug-filled component but also promotes uniform drug distribution and efficient absorption through the synergistic effect of the multi-layered structure, directly treating eye symptoms and significantly improving treatment efficacy. Moreover, different thicknesses of the drug-filled component can be installed according to different patients, better adapting to patients with varying degrees of eye protrusion and improving wearing comfort. Furthermore, the openings on both sides of the eye mask frame are equipped with protective covers and soft skin-contact layers. The protective covers effectively prevent external contamination and maintain internal cleanliness, while also allowing for ventilation of the eyes. The soft skin-contact layers provide additional comfort and skin protection, further enhancing the patient's user experience. Simultaneously, the medication placement frame and the eye mask frame are also equipped with snap-fit components and a medication dispensing port, simplifying the assembly, disassembly, cleaning, and medication addition processes, enabling patients or medical staff to easily manage the use and maintenance of the eye mask. Therefore, the eye mask for pregnant patients with hyperthyroidism and Graves' ophthalmopathy provided by this invention significantly improves patient comfort and enhances the efficiency and effectiveness of drug treatment, providing a safe, effective, and comfortable eye care mask for pregnant patients with hyperthyroidism and Graves' ophthalmopathy. Attached Figure Description
[0017] Figure 1 This is a schematic diagram of the eye mask for pregnant patients with hyperthyroidism and Graves' ophthalmopathy as described in this utility model; Figure 2 This is a schematic diagram showing the side of the eye patch facing the eye when worn by a pregnant patient with hyperthyroidism and Graves' ophthalmopathy. Figure 3 This is a schematic diagram of the disassembled structure of the eye mask frame; Figure 4 This is a schematic diagram of the cross-sectional structure of the eye mask frame perpendicular to its length axis. Figure 5 This is a schematic diagram of the cross-sectional structure of the drug delivery assembly.
[0018] in: 10-Eye mask frame, 20-Elastic band, 30-Connecting strap, 31-Helmet, 32-Helmet, 40-Protective cover, 50-Soft skin-contact layer, 60-Drug placement component, 61-Drug placement frame, 62-Absorbent layer, 63-Drug-absorbing pad layer, 64-Soft gauze layer, 70-Snap fastener assembly, 80-Drug dispensing port, 71-Snap fastener, 72-Groove, 73-Identification mark, 81-Soft silicone one-way cap. Detailed Implementation
[0019] The embodiments described below are merely some embodiments of this utility model, and not all embodiments. All other embodiments obtained by those skilled in the art based on the embodiments of this utility model without inventive effort are within the scope of protection of this utility model.
[0020] See Figures 1-5 This embodiment provides an eye mask for pregnant patients with hyperthyroidism and exophthalmos, comprising two identical eye mask frames 10. When the two eye mask frames 10 are connected, their opposite sides are provided with interlocking elastic bands 20. When the two eye mask frames 10 are connected, their opposite sides are provided with triangular connecting straps 30. When the two connecting straps 30 are connected, their opposite sides are respectively provided with a Velcro 31 and a Velcro 32. Both sides of the thickness direction of the two eye mask frames 10 are provided with openings, and a pivot connection is made on one side of one of the openings. A protective cover 40 is provided, the outer diameter of which is slightly smaller than or equal to the inner diameter of the opening. A soft skin-adhesive layer 50 is provided around the outer edge of one side of the other opening. A drug placement component 60 is detachably provided inside the eye mask frame 10. The drug placement component 60 includes a drug placement frame 61 and a drug-absorbing layer 62, a drug-absorbing padding layer 63, and a soft gauze layer 64 disposed on the drug placement frame 61. The drug placement frame 61 and the eye mask frame 10 are provided with a buckle component 70 and a drug dispensing port 80.
[0021] See Figure 2 , Figure 3 as well as Figure 4 Preferably, the buckle assembly 70 includes a buckle 71 annularly disposed on the outside of the drug-feeding frame, and a groove 72 recessed from the inner sidewall to the outer side of the eye mask frame 10. Further, the buckle 71 is a T-shaped buckle 71, and the groove 72 is a T-shaped groove 72 adapted to the T-shaped buckle 71. The design of the T-shaped buckle 71 and the T-shaped groove 72 ensures a stable connection between the drug-feeding assembly 60 and the eye mask frame 10, preventing it from falling off or shifting during use. It also makes the assembly and disassembly process simpler and faster, allowing users or medical personnel to easily complete the process without complicated operations. It should be noted that in this application, four buckles 71 and four grooves are provided.
[0022] See Figure 2Furthermore, each of the T-shaped buckles 71 and T-shaped grooves 72 is provided with an identification mark 73. When the medication placement component 60 is engaged with the eye mask frame 10, the identification mark 73 corresponds to the medication placement frame 61 and the medication inlet 80 on the eye mask frame 10. It should be noted that in this application, the medication inlet 80 is recessed from the outer side of the eye mask frame 10 to the inner side, and the medication placement frame 61 is also recessed from the outer side to the inner side.
[0023] See Figure 4 Furthermore, the medication inlet 80 is cylindrical. Both the medication placement frame 61 and the goggles frame 10 have a soft silicone one-way cap 81 on their cylindrical medication inlets 80. The protruding end of the soft silicone one-way cap 81 on the goggles frame 10 faces outwards, while the protruding end of the soft silicone one-way cap 81 on the medication placement frame 61 faces inwards. Furthermore, the soft silicone one-way cap 81 has a cross-shaped slit opening. The soft silicone one-way cap 81 not only maintains the airtightness of the medication inlet 80, preventing medication spillage or external contamination, but also, through its elasticity, allows the user to easily open it when medication needs to be added and automatically close it when not needed, ensuring the convenience and safety of the medication application process. Specifically, the protruding end of the soft silicone one-way cap 81 of the goggle frame 10 faces outwards to prevent external contaminants from entering through the medication inlet 80. Since the goggle may come into contact with various external environmental contaminants such as dust and bacteria during use, having the protruding end of the soft silicone one-way cap 81 facing outwards effectively blocks these contaminants from entering the goggle through the medication inlet 80, thus protecting the purity of the medication and the user's eye health. Secondly, the protruding end of the soft silicone one-way cap 81 of the medication placement frame 61 faces inwards. When medication overflows, the liquid surrounds the soft silicone one-way cap 81, creating positive pressure that closes the cross-shaped slit opening on the soft silicone one-way cap 81, preventing further overflow. It should be noted that when adding medication through the medication inlet 80, the inlet 80 can be disinfected with alcohol before inserting a syringe to slowly inject the medication.
[0024] Preferably, the elastic band 20 is provided with fastening components at both ends for adjusting the tightness of the elastic band 20. The fastening components can be Velcro or D-rings. This allows the eye mask to be personalized according to the head size and wearing needs of different patients, thereby ensuring optimal wearing comfort and stability.
[0025] Preferably, the openings on both sides of the goggle frame 10 of this application are connected, that is, they spread outward along the axis of the goggle frame 10, and are thus configured as through holes penetrating the middle of the goggle frame 10. The two ends of the through holes are the openings, and a support baffle is provided at the through hole in the middle of the goggle frame 10. The middle of the support baffle is configured as a through circular hole. When the protective cover 40 is fastened to the opening, the support baffle can act as abutting one end of the protective cover 40. At the same time, when the medication assembly 60 is installed, the support baffle acts as a stable support point, abutting one end of the medication assembly 60, ensuring that the assembly is accurately installed and aligned with the medication port 80, preventing the medication assembly 60 from falling off or shifting, and ensuring the continuous and effective release of the medication. At the same time, the through circular hole also serves to push the medication assembly 60 out from the protective cover 40 side using a sterilized tool.
[0026] Preferably, a rubber ring is provided inside the opening of the goggle frame 10 on one side of the protective cover 40, and the inner diameter of the rubber ring is the same as the outer diameter of the protective cover 40. The rubber ring ensures that the protective cover 40 can tightly seal the opening when it is fastened to the opening of the goggle frame 10.
[0027] Preferably, the soft skin-adhesive layer 50 is a soft rubber gasket. The absorbent layer 62 can be made of polymer, porous ceramic, activated carbon fiber, or sponge. The drug-absorbing pad layer 63 can be made of medical-grade non-woven fabric, sponge, or hydrogel. The drug-absorbing pad layer 63 has good permeability, allowing the drug to penetrate from the absorbent layer 62 to the soft gauze layer 64, thereby enabling the eyeglasses to absorb the drug. The soft gauze layer 64 can be made of pure cotton gauze, silk, or polyester. The soft gauze layer 64 is not only soft and comfortable but also has good breathability and antibacterial properties, effectively ensuring comfortable and safe eye care when it comes into contact with the eye. Preferably, a baffle is provided on the side of the absorbent layer 62 of the drug-absorbing component 60 away from the drug-absorbing pad layer 63 to prevent excessive leakage of the drug from that side.
[0028] This utility model provides an eye mask for pregnant patients with hyperthyroidism and exophthalmos, comprising two identical eye mask frames 10. When the two eye mask frames 10 are connected, a triangular connecting strap 30 is provided on the opposite side. The triangular connecting strap 30 is equipped with Velcro 31 and Velcro 32, so that the eye mask can flexibly adapt to the facial contours (interocular distance) and the degree of eye protrusion of different patients. The connection length of the connecting strap 30 can be adjusted to ensure optimal wearing comfort and fit, effectively avoiding the discomfort caused by the fixed size of traditional eye masks. At the same time, the triangular connecting strap 30 forms a notch at the bottom after connection, which can be aligned with the bridge of the user's nose, making the eye mask fit more closely. Secondly, the eye mask frame 10 features a detachable drug-filled assembly 60, comprising an absorbent layer 62, a drug-absorbing padding layer 63, and a soft gauze layer 64. This not only facilitates the replacement and installation of the drug-filled assembly 60 but also, through the synergistic effect of its multi-layered structure, promotes uniform distribution and efficient absorption of the medication, directly targeting eye symptoms and significantly improving treatment efficacy. Furthermore, different thicknesses of the drug-filled assembly 60 can be installed to better suit patients with varying degrees of eye protrusion, enhancing wearing comfort. In addition, the openings on both sides of the eye mask frame 10 are respectively equipped with protective covers 40 and soft skin-contact layers 50. The protective covers 40 effectively prevent external contamination, maintaining internal cleanliness while allowing for ventilation of the eyes. The soft skin-contact layers 50 provide additional comfort and skin protection, further enhancing the patient's user experience. Meanwhile, the medication placement frame 61 and the eye mask frame 10 are also equipped with a buckle assembly 70 and a medication dispensing port 80, which simplifies the assembly, disassembly, and medication addition process of the medication placement frame 61, allowing patients or medical staff to easily manage the use and maintenance of the eye mask. Therefore, the eye mask for pregnant patients with hyperthyroidism and Graves' ophthalmopathy provided by this utility model significantly improves the wearing comfort of patients and also improves the efficiency and effectiveness of drug treatment, providing a safe, effective, and comfortable eye care mask for pregnant patients with hyperthyroidism and Graves' ophthalmopathy.
[0029] The above-disclosed embodiments are merely some preferred embodiments of the present utility model, and should not be construed as limiting the scope of the present utility model. Therefore, any equivalent changes made in accordance with the scope of the present utility model patent application shall still fall within the scope of the present utility model.
Claims
1. A pair of eye masks for a pregnant patient with hyperthyroid exophthalmos, comprising two identical eye mask frames, characterized in that: When the two eye mask frames are connected, their opposite sides are provided with interlocking elastic bands. When the two eye mask frames are connected, their opposite sides are provided with a triangular connecting band. When the two connecting bands are connected, their opposite sides are provided with a Velcro closure and a Velcro closure, respectively. Both sides of the thickness direction of the two eye mask frames are provided with openings. A protective cover is pivotally provided on one side of one of the openings. The outer diameter of the protective cover is equal to or slightly smaller than the inner diameter of the opening. A soft skin-adhesive layer is provided around the outer edge of one side of the other opening. A drug-dispensing component is detachably provided inside the eye mask frame. The drug-dispensing component includes a drug-dispensing frame and a drug-absorbing layer, a drug-absorbing pad layer, and a soft gauze layer provided on the drug-dispensing frame. The drug-dispensing frame and the eye mask frame are provided with a buckle assembly and a drug dispensing port.
2. The eye mask for a pregnant patient with hyperthyroid exophthalmos according to claim 1, wherein The buckle assembly includes a buckle that is annularly disposed on the outside of the medication placement frame, and a groove that is recessed from the inner sidewall to the outer side of the eye mask frame.
3. The eye patch for pregnant women with hyperthyroidism and Graves' ophthalmopathy as described in claim 2, characterized in that, The buckle is a T-shaped buckle, and the groove is a T-shaped groove adapted to the T-shaped buckle.
4. The eye patch for pregnant women with Graves' ophthalmopathy as described in claim 3, characterized in that, The T-shaped buckle and the T-shaped groove are provided with identification marks, and the identification marks correspond to each other when the medicine placement component is engaged with the eye mask frame.
5. The eye patch for pregnant women with hyperthyroidism and exophthalmos as described in claim 3, characterized in that, The drug inlet is cylindrical. Both the drug inlet of the drug placement frame and the cylindrical drug inlet of the goggles frame are provided with soft silicone one-way caps. The protruding end of the soft silicone one-way cap of the goggles frame faces the outside of the goggles frame, and the protruding end of the soft silicone one-way cap of the drug placement frame faces the inside of the drug placement frame.
6. The eye patch for pregnant women with Graves' ophthalmopathy as described in claim 5, characterized in that, The soft silicone one-way cap is provided with a cross-shaped slit opening.
7. The eye patch for pregnant women with hyperthyroidism and exophthalmos as described in claim 1, characterized in that, The elastic band is equipped with fastening components at both ends for adjusting the tightness of the elastic band.
8. The eye patch for pregnant women with Graves' ophthalmopathy as described in claim 1, characterized in that, A support baffle is provided in the middle of the eye mask frame, and the middle of the support baffle is provided with a through circular hole.
9. The eye patch for pregnant women with hyperthyroidism and exophthalmos as described in claim 1, characterized in that, A rubber ring is provided inside the opening of the goggle frame on one side of the protective cover, and the inner diameter of the rubber ring is the same as the outer diameter of the protective cover.
10. The eye patch for pregnant women with hyperthyroidism and Graves' ophthalmopathy as described in claim 1, characterized in that, The soft skin-adhesive layer is a soft rubber gasket.